Clinical Status: GHK-Cu is an endogenous copper-binding peptide studied in both animal and human research models for wound healing, skin regeneration, and anti-aging applications
2015 May;1(3):179-196
BPC-157 : TB500 (Thymosin Beta 4) : BPC-157 & TB500 (Thymosin Beta 4) CERTIFICATES OF ANALYSIS 6 COAs BN-26BT11-001 Current Variant: Size: 10mg-10mg BPC-157 11.7 mg / 11.85 mg TB-500 11.54 mg / 11.44 mg BN-25BT55-004 Current Variant: Size: 5mg-5mg BPC-157 5.89 mg / 5.73 mg TB-500 5.68 mg / 5.57 mg BN-24BT55 Upcoming Variant: Size: 5mg-5mg BPC-157 5.57 mg TB-500 5.49 mg BN-25BT11-002 Previous Variant: Size: 10mg-10mg BN-25BT11-001 Previous Variant: Size: 10mg-10mg BN-24BT55-001 Previous Variant: 5 mg / 5 mg Formulation BPC-157 and TB-500 (Thymosin Beta-4) are research peptides supplied for use in controlled laboratory and analytical environments
Hillary Lin, MD Important clarification of where compounding, translational evidence, and online claims often diverge
Some research-planning protocols use 5 mL of BAC water for a 200 mg/mL high-concentration option, which reduces injection volume but requires more careful syringe measurement
Another study showed that vitamin D supplementation during pregnancy of 5,000 IUs a day and during infancy and childhood of 1,000 ius a day reduced the incidence of autism from 20% to 5% for mothers who already had one autistic child
